Faster paths to mRNA therapeutics with IVT-ready DNA
Webinars

Faster paths to mRNA therapeutics with IVT-ready DNA

Cell-free gene synthesis removes key bottlenecks in mRNA synthesis, accelerating the development of lifesaving therapies.

The rise of mRNA technology has created new possibilities for developing vaccines, cancer therapies, and treatments for genetic diseases. However, producing mRNA still faces challenges, especially when preparing DNA templates for in vitro transcription (IVT). Traditional plasmid-based methods are often slow, inconsistent, and difficult to scale. In this webinar, Galit Meshulam-Simon, Nicholas McGlincy, and Ankur Sarkar will discuss a cell-free approach for producing high-complexity, linear, IVT-ready DNA templates, enabling faster and more consistent mRNA synthesis.

Topics to be covered:

  • Major challenges in robust mRNA production 
  • A robust, cell-free approach for producing linear IVT-ready DNA templates 
  • How linear IVT-ready DNA templates perform compared to traditional plasmid-based methods 

Thursday, August 14th, 2025 | 11:00 AM - 1:00 PM Eastern Time
This webinar will be available to view live and on demand.


Speakers

Galit Meshulam-Simon, PhD

Galit Meshulam-Simon, PhD
Associate Director, Commercial Applications
Elegen

Nicholas McGlincy, PhD

Nicholas McGlincy, PhD
Senior Scientist, Commercial Applications
Elegen

Ankur Sarkar, PhD

Ankur Sarkar, PhD
Senior Scientist, Molecular Biology
Elegen

Sponsored by

  • elegen logo

Top Image Credit:

iStock: nopparit